World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
22834
World Ranking
19955
National Ranking
674

Sylvie Castaigne publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sylvie Castaigne sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 257 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sylvie Castaigne D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sylvie Castaigne sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sylvie Castaigne is affiliated with Versailles Saint-Quentin-en-Yvelines University in France. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology.

Their main subfields of study include Hematology, Molecular Biology, Epidemiology, Public Health, Environmental and Occupational Health, and Neurology.

Castaigne's work focuses extensively on Acute Myeloid Leukemia Research, covering topics such as Epigenetics and DNA Methylation, Acute Lymphoblastic Leukemia research, Retinoids in leukemia and cellular processes, Neuroblastoma Research and Treatments, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, and Histone Deacetylase Inhibitors Research.

Among recent papers authored or co-authored by Castaigne are:

  • Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow, 2020, Cell Reports
  • Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment, 2020, International Journal of Molecular Sciences
  • Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML, 2021, Blood Advances
  • Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia, 2021, Bone Marrow Transplantation
  • A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis, 2020, Leukemia

The most frequent publication venues for Castaigne's research include Blood, Cell Reports, International Journal of Molecular Sciences, Blood Advances, and Bone Marrow Transplantation.

Frequent co-authors collaborating with Castaigne are:

  • Hervé Dombret
  • Claude Preudhomme
  • Juliette Lambert
  • Cécile Pautas
  • Sylvain Chantepie

Best Publications

  • All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

    Sylvie Castaigne;Christine Chomienne;Marie Therese Daniel;Paola Ballerini

  • Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

    Bertrand Coiffier;Catherine Thieblemont;Eric Van Den Neste;Gérard Lepeu

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

    Sylvie Castaigne;Cécile Pautas;Christine Terré;Emmanuel Raffoux

  • Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: A meta-analysis of individual patient data from randomised controlled trials

    Robert Kerrin Hills;Sylvie Castaigne;Frederick R. Appelbaum;Jacques Delaunay

  • Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

    P Fenaux;MC Le Deley;S Castaigne;E Archimbaud

  • Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).

    Claude Preudhomme;Christophe Sagot;Nicolas Boissel;Jean-Michel Cayuela

  • Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

    Frédéric Peyrade;Fabrice Jardin;Catherine Thieblemont;Antoine Thyss

  • All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship

    Christine Chomienne;Paola Ballerini;Nicole Balitrand;Marie Therese Daniel

  • All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

    L Degos;H Dombret;C Chomienne;M T Daniel

  • Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.

    H Tilly;S Castaigne;D Bordessoule;P Casassus

  • Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

    Lionel Adès;Lionel Adès;Agnes Guerci;Emmanuel Raffoux;Miguel Sanz

  • All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

    P Fenaux;S Castaigne;H Dombret;E Archimbaud

  • Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.

    Mats Brune;Sylvie Castaigne;John Catalano;Kurt Gehlsen

  • Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

    Stéphane Prost;Francis Relouzat;Marc Spentchian;Yasmine Ouzegdouh

  • Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

    Juliette Lambert;Cécile Pautas;Christine Terré;Emmanuel Raffoux

  • High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

    A.-L. Taksin;O. Legrand;E. Raffoux;T. De Revel

  • Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.

    Nicolas Boissel;Aline Renneville;Valeria Biggio;Nathalie Philippe

  • Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study

    Cecile Pautas;Fatiha Merabet;Xavier Thomas;Emmanuel Raffoux

  • Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.

    L Delva;M Cornic;N Balitrand;F Guidez

Frequent Co-Authors

Hervé Dombret
Hervé Dombret Université Paris Cité
Claude Preudhomme
Claude Preudhomme University of Lille
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis
Aline Renneville
Aline Renneville Institut Gustave Roussy
Sylvie Chevret
Sylvie Chevret Université Paris Cité
Christine Chomienne
Christine Chomienne Université Paris Cité
Nicolas Boissel
Nicolas Boissel Université Paris Cité
Stéphane de Botton
Stéphane de Botton Institut Gustave Roussy
Xavier Thomas
Xavier Thomas Lyon College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers related to medicine, online degree options are expanding at a rapid pace. From nursing to healthcare management, flexible online programs are helping students enter or advance in rewarding fields.

If you’re looking for the easiest dnp program online, several universities offer streamlined options designed for working nurses who want to earn a Doctor of Nursing Practice degree without sacrificing their current roles. These online programs often feature part-time and full-time formats.

Those wanting to start their healthcare career quickly may consider fast track medical programs, such as online LPN certificates. These programs can provide a quick entry point into the nursing workforce.

For advanced specialization, accelerated msn psychiatric np programs help qualified nurses become psychiatric mental health nurse practitioners faster, meeting rising mental health needs.

Not all healthcare roles require clinical work. Earning an online healthcare administration degree prepares graduates for vital leadership roles in medical organizations – often entirely online and at an affordable cost.

Best Scientists Citing Sylvie Castaigne

Trending Scientists

Recently Published Articles